On this page
WNT1
Wnt family member 1
WNT1 is located on the long (q) arm of chromosome 12, at band 12q13.12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 12 in the library →Available at Jeen Health
Clinical tests that include this
Overview
WNT1 encodes a member of the WNT protein family, which plays fundamental roles in cell-to-cell communication during embryonic development and tissue maintenance. The protein acts as a signalling molecule, binding to receptors on neighbouring cells to trigger pathways that control bone formation, skeletal patterning, and nervous system development.
Variants in WNT1 are inherited in an autosomal recessive pattern, meaning that two altered copies of the gene are typically required for clinical features to manifest. Individuals with one pathogenic variant are generally unaffected carriers. Testing for WNT1 variants forms part of carrier screening programmes, particularly for couples planning pregnancy, as well as diagnostic pathways for skeletal disorders recognised by the NHS Genomic Medicine Service.
What the gene does
The WNT1 protein functions as a secreted ligand within the canonical WNT signalling pathway, a highly conserved system that regulates cell proliferation, differentiation, and tissue organisation. Once secreted from a cell, WNT1 binds to Frizzled receptors and LRP5/6 co-receptors on target cells, initiating an intracellular cascade that stabilises beta-catenin and ultimately influences gene transcription.
In bone biology, WNT1 signalling is particularly critical for osteoblast differentiation and function. The protein promotes the formation and activity of bone-building cells, supporting both skeletal development in utero and bone density maintenance throughout life. Research suggests that WNT1 also contributes to neural development, particularly in the midbrain and hindbrain regions during early embryogenesis. Disruption of this signalling network can compromise skeletal integrity and, in some instances, affect neurological development.
Video: Genetics 101
Chromosome location
WNT1 is located on chromosome 12 at position 12q13.12. The gene spans a relatively compact genomic region and encodes a transcript that produces a 370-amino-acid protein. The chromosomal band 12q13 contains several genes involved in developmental signalling pathways, though WNT1 variants typically cause skeletal phenotypes distinct from neighbouring gene abnormalities.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Pathogenic variants in WNT1 encompass loss-of-function changes that reduce or eliminate protein activity. These include nonsense variants that introduce premature stop codons, frameshift variants caused by small insertions or deletions, and missense variants affecting critical functional regions. Certain missense changes cluster in residues essential for receptor binding or protein secretion, disrupting the protein's ability to activate downstream signalling.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Autosomal recessive WNT1 variants are associated with osteogenesis imperfecta, a group of conditions characterised by bone fragility and increased fracture risk. Some individuals present with skeletal features alongside intellectual disability or brain abnormalities, reflecting the gene's dual role in bone and neural development. The phenotypic spectrum ranges from moderate bone fragility with normal cognitive function to more severe skeletal dysplasia accompanied by developmental delay. Fetal skeletal abnormalities may occasionally be detected during antenatal imaging, prompting genetic investigation.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic WNT1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
WNT1 appears on multiple NHS England PanelApp gene panels reflecting its clinical relevance. The gene holds green (high-evidence) classification on the Osteogenesis imperfecta panel (R102), Skeletal dysplasia panel (R104), and Intellectual disability panel (R29). It is also included in the DDG2P database and the Fetal anomalies panel (R21), supporting its use in prenatal and postnatal diagnostic pathways across NHS genomic services.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does it mean to be a carrier of a WNT1 variant?
A carrier has one pathogenic variant in WNT1 and one typical copy. Carriers generally do not have symptoms because the functional copy produces sufficient protein. However, if both parents are carriers, each pregnancy has a 25% chance of inheriting two pathogenic variants, which may cause a skeletal condition.
How are WNT1 variants inherited?
WNT1-related conditions follow autosomal recessive inheritance. An affected individual inherits one pathogenic variant from each parent, both of whom are typically unaffected carriers. Genetic counselling can help families understand recurrence risk and testing options for relatives.
Is WNT1 testing available on the NHS?
Yes, WNT1 is included in several NHS genomic testing pathways, particularly for skeletal disorders, developmental delay, and foetal anomalies. Testing eligibility depends on clinical presentation and family history, and is coordinated through regional genomic medicine services with genetic counsellor support.